Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp SRBCF


Primary Symbol: V.SBM

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

Sirona Biochem Corporate Update

GlobeNewswire July 12, 2022

Sirona Biochem (TSXV:SBM) contracts WuXi AppTec to manufacture anti-aging compound for clinical trial

John Ballem  June 22, 2022

Sirona Biochem Contracts WuXi AppTec to Manufacture Revolutionary Anti-Aging/Anti-Wrinkle Compound for Clinical Trial

GlobeNewswire June 22, 2022

Dr. Wolfgang Bieber joins Sirona Biochem's (TSXV:SBM) advisory board

John Ballem  June 20, 2022

Former Bayer Senior Executive Joins Sirona Biochem Advisory Board

GlobeNewswire June 20, 2022

Sirona Biochem Initiates Significant Corporate Changes

GlobeNewswire June 15, 2022

Sirona Biochem (TSX-V:SBM) announces exclusive agreement with Allergan Aesthetics

Shoran Devi June 13, 2022

Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics

GlobeNewswire June 13, 2022

Sirona Biochem CEO Quarterly Update

GlobeNewswire April 11, 2022

Sirona Biochem Subsidiary, TFChem, Awarded Financing in Partnership with French Government

GlobeNewswire March 9, 2022

Sirona Biochem Renews Agreement with CURE Intelligence for Marketing and Communications Support

GlobeNewswire January 18, 2022

Sirona Biochem Sponsors Fluorine Chemistry Symposium, Normandy, France

GlobeNewswire January 12, 2022

Sirona Biochem CEO Quarterly Update

GlobeNewswire January 4, 2022

Sirona Biochem Antiviral Compounds to be Tested Against SARS-CoV-2 by Top US Testing Facility

PR Newswire December 20, 2021

Sirona Biochem Announces Engagement of Pullan Consulting to Close Optimal Deal for TFC-1067

PR Newswire December 16, 2021

Sirona Biochem Provides Update on SGLT2 Inhibitor for Type 2 Diabetes in China

PR Newswire December 13, 2021

Sirona Biochem Announces 2021 Annual Meeting Results: Shareholders Approve All Resolutions With Majority Vote

PR Newswire November 10, 2021

/R E P E A T -- Sirona Biochem: Investing News Network Interview with CEO, Dr. Howard Verrico/

PR Newswire October 12, 2021

Sirona Biochem: Investing News Network Interview with CEO, Dr. Howard Verrico

PR Newswire October 12, 2021

/R E P E A T -- Sirona Biochem Announces Advancement of TFC-1067/

PR Newswire October 6, 2021